DNAzymes, Novel Therapeutic Agents in Cancer Therapy: A Review of Concepts to Applications
The past few decades have witnessed a rapid evolution in cancer drug research which is aimed at developing active biological interventions to regulate cancer-specific molecular targets. Nucleic acid-based therapeutics, including ribozymes, antisense oligonucleotides, small interference RNA (siRNA),...
Guardado en:
Autores principales: | I. B. K. Thomas, K. A. P. Gaminda, C. D. Jayasinghe, D. T. Abeysinghe, R. Senthilnithy |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Hindawi Limited
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ca8513edb3f74fd49cd2192d985f38fa |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Perturbing the Normal Level of SIDT1 Suppresses the Naked ASO Effect
por: Masayuki Takahashi, et al.
Publicado: (2021) -
Leading individual features of antioxidant systematically classified by the ORAC assay and its single electron transfer and hydrogen atom transfer reactivities; analyzing ALS therapeutic drug Edaravone
por: Miwa Takatsuka, et al.
Publicado: (2021) -
The insulin centennial—100 years of milestones in biochemistry
por: Alan D. Attie, et al.
Publicado: (2021) -
Disease-modifying therapeutic strategies in osteoarthritis: current status and future directions
por: Yongsik Cho, et al.
Publicado: (2021) -
Epigenetic modulation of selected immune response genes and altered functions of T lymphocytes and macrophages collectively contribute to autoimmune diabetes protection
por: Arathi Jayaraman, et al.
Publicado: (2021)